Anavex Life Sciences Corp (AVXL)

[kld2]

it ever occur to you that these same when and women, working for years on clinical development of a molecule, nursing it, believing in it, fail miserably--that's my point. About 91% of the time the molecule doesn't work out. That's my point. I am sure if you had asked them at any point in the development if this was the ONE, they would have responded in the affirmative, they who know more than anyone else about the molecule. And I find it absolutely risible that retail investors give credence to message board experts. Not saying it's not worth the dd; just saying an investment thesis based on dd is usually worthless, and especially with a drug like 2-73. Heck, nobody's even in agreement on what, specifically, causes AD, so how can you be so certain, through dd, that the drug itself will work?